ISRIB plus bortezomib triggers paraptosis in breast cancer cells via enhanced translation and subsequent proteotoxic stress.

MLA

Lee, Dong Min, et al. “ISRIB plus Bortezomib Triggers Paraptosis in Breast Cancer Cells via Enhanced Translation and Subsequent Proteotoxic Stress.” Biochemical and Biophysical Research Communications, vol. 596, Mar. 2022, pp. 56–62. EBSCOhost, https://doi.org/10.1016/j.bbrc.2022.01.082.

APA

Lee, D. M., Seo, M. J., Lee, H. J., Jin, H. J., & Choi, K. S. (2022). ISRIB plus bortezomib triggers paraptosis in breast cancer cells via enhanced translation and subsequent proteotoxic stress. Biochemical and Biophysical Research Communications, 596, 56–62. https://doi.org/10.1016/j.bbrc.2022.01.082

Chicago

Lee, Dong Min, Min Ji Seo, Hong Jae Lee, Hyo Joon Jin, and Kyeong Sook Choi. 2022. “ISRIB plus Bortezomib Triggers Paraptosis in Breast Cancer Cells via Enhanced Translation and Subsequent Proteotoxic Stress.” Biochemical and Biophysical Research Communications 596 (March): 56–62. doi:10.1016/j.bbrc.2022.01.082.